LiPOP1-NanoLuc
(Plasmid
#168265)
-
PurposeChemo-optogenetic control of necroptotic cell death by coupling LiPOP1 with NanoLuc-aided bioluminescence optogenetic stimulation (NanoLOGS)
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 168265 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonemCherry2-N1
-
Backbone manufacturerAddgene
- Backbone size w/o insert (bp) 4750
- Total vector size (bp) 7122
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameMLKL(1-125)
-
SpeciesH. sapiens (human)
-
MutationH15A, K16A, R17A
-
GenBank IDNM_152649.3
-
Entrez GeneMLKL (a.k.a. hMLKL)
- Promoter CMV
-
Tag
/ Fusion Protein
- mCherry, NanoLuc, CRY2-PHR (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NheI (not destroyed)
- 3′ cloning site NheI (not destroyed)
- 5′ sequencing primer CMV-For
- 3′ sequencing primer Sv40pA-R (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
LiPOP1-NanoLuc was a gift from Yubin Zhou (Addgene plasmid # 168265 ; http://n2t.net/addgene:168265 ; RRID:Addgene_168265) -
For your References section:
Optogenetic Control of Non-Apoptotic Cell Death. He L, Huang Z, Huang K, Chen R, Nguyen NT, Wang R, Cai X, Huang Z, Siwko S, Walker JR, Han G, Zhou Y, Jing J. Adv Sci (Weinh). 2021 May 6;8(13):2100424. doi: 10.1002/advs.202100424. eCollection 2021 Jul. 10.1002/advs.202100424 PubMed 34540558